STAT

Opinion: Eliminating ‘tensions’ in health care: a litmus test for innovation

The challenge in applying the term innovation in health care is that the relationship between the "buyer" (patient) and the "seller" (provider) is convoluted by many other players.

The term “innovation,” once considered an insult in religious sectors, has garnered a cult following in health care. Dozens of health innovation accelerators, incubators, labs, and centers now exist in universities, nonprofit institutions, and corporations across the country, and new ones are emerging all the time.

It is easy to understand why: the promise of innovation is astounding. Innovation done well can improve health care outcomes, decrease costs, serve more people, create market share, and help institutions gain cutting-edge reputations. And as health care spending approaches 20% of the U.S. economy, it’s apparent why the concept holds so much appeal for decision-makers and innovators.

Yet and liberally labeling projects as “innovations” pose threats of equal proportion. We believe there is value in innovation and want to protect it, but to do so it’s important to discern what it really

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT1 min read
USDA Faulted For Disclosing Scant Information About Outbreaks Of H5N1 Avian Flu In Cattle
With 28 herds in eight states infected with H5N1 bird flu, scientists are calling on the U.S. to release more data to help them assess the risk.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks